Hepatitis C

Sofosbuvir + Ravidasvir NCT02961426
Phase II/III, multicenter, multi-country, trial to assess the efficacy, safety, tolerance, and pharmacokinetics of sofosbuvir plus ravidasvir for the treatment of HCV infection.
puce ClinicalTrials.gov